Collectively, these results suggest that IFITM1 is closely involved in MPNST pathogenesis and that IFN-γ is a good candidate for the therapeutic treatment of MPNSTs in NF1. The gene discussed is IFNG; the disease is malignant peripheral nerve sheath tumor.